These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33465606)

  • 1. Chemokines, cytokines and substance use disorders.
    Ahearn OC; Watson MN; Rawls SM
    Drug Alcohol Depend; 2021 Mar; 220():108511. PubMed ID: 33465606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FACS analysis of neuronal-glial interactions in the nucleus accumbens following morphine administration.
    Schwarz JM; Smith SH; Bilbo SD
    Psychopharmacology (Berl); 2013 Dec; 230(4):525-35. PubMed ID: 23793269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.
    Watkins LR; Hutchinson MR; Ledeboer A; Wieseler-Frank J; Milligan ED; Maier SF
    Brain Behav Immun; 2007 Feb; 21(2):131-46. PubMed ID: 17175134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.
    Lacagnina MJ; Rivera PD; Bilbo SD
    Neuropsychopharmacology; 2017 Jan; 42(1):156-177. PubMed ID: 27402494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial and neuroinflammatory targets for treating substance use disorders.
    Bachtell RK; Jones JD; Heinzerling KG; Beardsley PM; Comer SD
    Drug Alcohol Depend; 2017 Nov; 180():156-170. PubMed ID: 28892721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of neuroimmune signaling and glutamate plasticity in addiction.
    Gipson CD; Rawls S; Scofield MD; Siemsen BM; Bondy EO; Maher EE
    J Neuroinflammation; 2021 Feb; 18(1):56. PubMed ID: 33612110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review.
    Karimi-Haghighi S; Chavoshinezhad S; Mozafari R; Noorbakhsh F; Borhani-Haghighi A; Haghparast A
    Cell Mol Neurobiol; 2023 Mar; 43(2):649-682. PubMed ID: 35461410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of dopamine and glutamate co-release in the nucleus accumbens in mediating the actions of drugs of abuse.
    Buck SA; Torregrossa MM; Logan RW; Freyberg Z
    FEBS J; 2021 Mar; 288(5):1462-1474. PubMed ID: 32702182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial mechanisms underlying substance use disorders.
    Linker KE; Cross SJ; Leslie FM
    Eur J Neurosci; 2019 Aug; 50(3):2574-2589. PubMed ID: 30240518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAK1 inhibition in mouse astrocyte cultures ameliorates cytokine-induced chemokine production and neutrophil migration.
    Soto-Díaz K; Juda MB; Blackmore S; Walsh C; Steelman AJ
    J Neurochem; 2020 Mar; 152(6):697-709. PubMed ID: 31782806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.
    El-Hage N; Wu G; Wang J; Ambati J; Knapp PE; Reed JL; Bruce-Keller AJ; Hauser KF
    Glia; 2006 Jan; 53(2):132-46. PubMed ID: 16206161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chemokines in Parkinson's disease.
    Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH
    Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS.
    Rezaie P; Trillo-Pazos G; Everall IP; Male DK
    Glia; 2002 Jan; 37(1):64-75. PubMed ID: 11746784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review on Cross Talk between Neurotransmitters and Neuroinflammation in Striatum and Cerebellum in the Mediation of Motor Behaviour.
    Abg Abd Wahab DY; Gau CH; Zakaria R; Muthu Karuppan MK; A-Rahbi BS; Abdullah Z; Alrafiah A; Abdullah JM; Muthuraju S
    Biomed Res Int; 2019; 2019():1767203. PubMed ID: 31815123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine transporters and psychostimulant addiction.
    Howell LL; Kimmel HL
    Biochem Pharmacol; 2008 Jan; 75(1):196-217. PubMed ID: 17825265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines released from astrocytes promote chemokine receptor 5-mediated neuronal cell differentiation.
    Park MH; Lee YK; Lee YH; Kim YB; Yun YW; Nam SY; Hwang SJ; Han SB; Kim SU; Hong JT
    Exp Cell Res; 2009 Oct; 315(16):2715-26. PubMed ID: 19559698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?
    Niciu MJ; Henter ID; Sanacora G; Zarate CA
    World J Biol Psychiatry; 2014 Jan; 15(1):2-16. PubMed ID: 24024876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.
    Johnson BA
    CNS Drugs; 2005; 19(10):873-96. PubMed ID: 16185095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal pathways linking substance P to drug addiction and stress.
    Commons KG
    Brain Res; 2010 Feb; 1314():175-82. PubMed ID: 19913520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity.
    Araos P; Pedraz M; Serrano A; Lucena M; Barrios V; García-Marchena N; Campos-Cloute R; Ruiz JJ; Romero P; Suárez J; Baixeras E; de la Torre R; Montesinos J; Guerri C; Rodríguez-Arias M; Miñarro J; Martínez-Riera R; Torrens M; Chowen JA; Argente J; Mason BJ; Pavón FJ; Rodríguez de Fonseca F
    Addict Biol; 2015 Jul; 20(4):756-72. PubMed ID: 24854157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.